logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong Stock Movement | Haiqing Zhiyuan (01392.HK) surges 17% intraday, combining multispectral perception capabilities with embodied carriers such as humanoid robots for implementation

date
20/10/2026
Zhitong Finance APP has learned that Haiqing Zhiyuan (01392.HK) rose as much as 17% this morning. As of press time, it was up 10.36% at HK$18.96, with a turnover of HK$61.8212 million.
Latest
2 m ago
Traders familiar with the deals said Asian refiners in South Korea and India recently purchased US crude loaded for November shipment. India's Bharat Petroleum Corp (BPCL) and South Korea's SK Energy each bought one Aframax cargo of US crude, with each cargo about 750,000 barrels. Seoul-based GS Caltex purchased a Very Large Crude Carrier (VLCC) cargo from Chevron, with the cargo volume at about 2 million barrels.
5 m ago
MINISO (09896.HK) repurchased 98,600 shares for US$252,000 on October 19.
7 m ago
Zhenro Properties (06158): Hearing on winding-up petition against ZHENRO HONG KONG LIMITED adjourned to November 9
8 m ago
AstraZeneca (AZN.O): The related projects under its collaboration with Oracle (ORCL.N) will cover core disease areas including oncology, cardiovascular, renal and metabolic diseases, respiratory, immunology, and rare diseases.
11 m ago
According to the Financial Times: Alphabet's President of Global Affairs and Chief Legal Officer refutes Europe's concerns about US dominance in artificial intelligence.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.